News & Analysis on Clinical Trial Services & Contract Research And Development
Canadian contract manufacturer Patheon has teamed up with specialty pharmaceutical firm Depomed to offer its clients a controlled release formulation which can grant their drugs increased bioavailability and less frequent dosing.
Industrial enzyme maker Novozymes is seeking to strengthen its presence in the biopharmaceutical market by offering to acquire Australian biotechnology firm Gropep for AUD83.6m (€49.6m), eager to become a supplier of recombinant ingredients for the...
India is holding the lion's share of the world's contract research business as activity in the pharma market continues to explode in this region.
Jacobs Engineering Group has inked a new contract with Boehringer Ingelheim to provide technical and construction services for its new bulk active pharmaceutical ingredient (API) facility being built in Petersburg, Virginia, US.
Biopharmaceutical firm Altus has asked contract manufacturer Althea to produce Phase III quantities of a crystallised formulation of human growth hormone (hGH) which can be administered subcutaneously weekly instead of daily.